| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
| mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
| mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
| mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
3e-06 |
| mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
5e-06 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
4e-05 |